Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-010658

Chief Scientific Officer sold 5,000 shares at $13.06 ($65,311)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2023-02-15 Sale −5,000 $13.06 $65,311 91,386 D
Open-market sales · 5,000 sh · avg $13.06 · $65,311
Loading xslF345X03/doc4.xml…